Mohammad Hosein BIGTANKazem MAHANPOOR2024-10-172017-03-30A. Grimm, K. Madduri, A. Ali, C.R. Hutchinson, Gene, 1994, 151, 1. A. Brayfield, ed. "Doxorubicin". Martindale: The Complete Drug Reference. Pharmaceutical Press, 2013. S.N. Mahnik, K. Lenz, N. Weissenbacher, R.M. Mader, M. Fuerhacker, Chemosphere, 2007, 66, 30. Z. Chen, G. Park, P. Herckes, P. Westerhoff, J. Adv. Oxid. Technol., 2008, 11, 254. J. Hirose, F. Kondo, T. Nakano, T. Kobayashi, N. Hiro, Y. Ando, H. Takenaka, K. Sano, Chemosphere, 2005, 60, 1018. C.A. Somensi, E.L. Simionatto, J.B. Dalmarco, P. Gaspareto, C.M. Radetski, J. Environ. Sci. Health A., 2012, 47, 1543. X.H. Wang, A.Y.C. Lin, Environ. Pollut., 2014, 186, 203. N. De la Cruz, J. Giménez, S. Esplugas, D. Grandjean, L.F. De Alencastro, C. Pulgarín, Water Res., 2012, 46, 1947. A. Chatzitakis, C. Berberidou, I. Paspaltsis, G. Kyriakou, T. Sklaviadis, I. Poulios, Water Res., 2008, 42, 386. E. Aghaei, M. Haghighi, Powder Technol., 2015, 269, 358. M. Nikazar, K. Gholivand, K. Mahanpoor, Kinet. Catal., 2007, 48, 214. J.M. Wu, T.W. Zhang, J. Photochem. Photobiol. A., 2004, 162, 171. E. Pipelzadeh, A.A. Babaluo, M. Haghighi, A. Tavakoli, M. Valizadeh Derakhshan, A. Karimzadeh Behnami, Chem. Eng. J., 2009, 155, 660. Y.X. Yang, M.L. Liu, H. Zhu, Y.R. Chen, G.J. Mu, X.N. Liu, Y.Q. Jia, J. Magn. Magn. Mater., 2008, 320, L132. N.K. Chaudhari, H.C. Kim, D. Son, J.-S. Yu, Cryst. Eng. Comm., 2009, 11, 2264. E. Aghaei, M. Haghighi, Powder Technol., 2015, 269, 358.1224-7154(online): 2065-9520http://dspace.chem.ubbcluj.ro:4000/handle/20.500.14637/51STUDIA UBB CHEMIA, LXII, 1, 2017 (p. 203-212), DOI:10.24193/subbchem.2017.1.18 Mohammad Hosein BIGTAN Department of Chemistry, Arak Branch, Islamic Azad University, Arak, Iran Kazem MAHANPOOR Department of Chemistry, Arak Branch, Islamic Azad University, Arak, Iran *Corresponding author: k-mahanpoor@iau-arak.ac.irIn this investigation, α-Fe₂O₃/SAPO-34 nano-structure were synthesized and characterized by XRD, SEM and FT-IR techniques. Morphologically, the shape of α-Fe₂O₃/SAPO-34 nanoparticles is close to spherical nanoparticles with an average particle size of 93 nm determined by Debye-Scherrer equation. The photocatalytic activity of α-Fe₂O₃/SAPO-34 nanostructure was investigated through the degradation of doxorubicin, an anti-cancer drug using a batch reactor under UV-C irradiation and H₂O₂ as oxidant. The effect of various factors including drug concentration, catalyst dosage, pH and H₂O₂ concentration on the degradation yield were investigated. The results showed that optimum conditions were: Initial concentration of DOX = 20 ppm, pH = 8, amount of α-Fe₂O₃/SAPO-34 = 150 mg/L, and H₂O₂ concentration 4 mol/L.enDoxorubicinPhotocatalytic degradationα-Fe₂O₃/SAPO-34NanocatalystArticle